July 5 (Reuters) - Endo International Plc ENDP.O
* Endo announces divestiture of grupo farmacéutico somar
* Endo announces divestiture of grupo farmacéutico somar
* Endo international plc - deal for approximately $124 million
* Says to sell mexico city based grupo farmacéutico somar to advent international for approximately $124 million
* Endo international plc - deal for approximately $124 million
* Endo international plc - endo intends to classify somar assets and liabilities as held-for-sale in second-quarter 2017
* Endo international plc - expects to record estimated pre-tax impairment charge of approximately $100 million
* Endo international- will finalize analysis and record any required impairment charges in connection with second-quarter 2017 financial reporting close
* Endo international - will finalize analysis,record required impairment charges in connection with its second-quarter 2017 financial reporting close Source text for Eikon: ID:nCNWd64vda Further company coverage: ENDP.O